FCSC Stock, Fibrocell Science Inc. Information

Fibrocell Science Inc is active in the healthcare sector. It is an autologous cell and gene therapy company focused on discovering and developing localized therapies for diseases affecting the skin, connective tissue, and joints. Its gene-therapy product candidate, FCX-007, is in pre-clinical development for the treatment of recessive dystrophic epidermolysis bullosa and its gene-therapy product candidate, FCX-013, is in pre-clinical development for the treatment of linear scleroderma.